Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Uterine Neoplasms 1 Pancreatic Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

Cisplatin 90 Fluorouracil 76 Radiotherapy 63 Paclitaxel 58 Docetaxel 49 Oxaliplatin 48 Irinotecan 42 Leucovorin 32 Capecitabine 31 Carboplatin 27 Radiation 21 Surgical Procedures, Operative 20 Esophagectomy 20 pembrolizumab 15 Neoadjuvant Therapy 15 Bevacizumab 15 Cetuximab 13 Drug Therapy 12 Epirubicin 11 Chemotherapy, Adjuvant 9 S 1 (combination) 8 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Trastuzumab 7 Nivolumab 7 Erlotinib Hydrochloride 7 Surveys and Questionnaires 6 Panitumumab 6 Immunohistochemistry 6 Chemoradiotherapy 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Esophageal Neoplasms × ferumoxtran-10 × Clear all

NCT02253602 2019-01-16

IMPROVE

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡